Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer Metastatic

Explore clinical trials studying Breast Cancer Metastatic. Study availability and eligibility vary by location and protocol.

73 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer Metastatic trial results

Completed

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

NCT02000622

Conditions
BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Cancer Metastatic, +10 more
Locations
  • Research Site San Diego, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Whittier, California, United States
  • Research Site Denver, Colorado, United States
View all 171 locations
View Trial Details
Completed

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

NCT03321981

Conditions
Breast Cancer Metastatic, Lethal Congenital Contracture Syndrome 2
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • HCA Midwest Health Kansas City, Kansas, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Institut Jules Bordet Brussels, Belgium
View all 25 locations
View Trial Details
Completed

Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)

NCT04240106

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Diseases, +5 more
Locations
  • Centro Oncologico de Galicia A Coruña, Spain
  • Complejo Asistencial de Ávila Ávila, Spain
  • Hospital Uniersitario Vall d'Hebron Barcelona, Spain
  • Hospital Clínic i provincial de Barcelona Barcelona, Spain
View Trial Details

Related conditions